Sign up USA
MabVax Therapeutics (OTCMKTS:MBVX)

MabVax Therapeutics (OTCMKTS:MBVX)


Share Price
$ 0.46
Change
0.04 (9.64 %)
Market Cap
$4.08 m
Proactive Investors - Run By Investors For Investors

MabVax Therapeutics

MabVax Therapeutics Holdings is a clinical stage oncology drug development company focused on the development of human antibody-based products and vaccines to address unmet medical needs in the treatment of cancer.

EPIC: MBVX
Market: OTCBB:MBVX
52-week High/Low: $3.27 / $0.26
Sector: Pharma & Biotech
Market Cap: $4.08M
Website: www.mabvax.com

MabVax Therapeutics

www.mabvax.com

Interactive graph

col 3
col 4
col 5
col 6

MabVax Therapeutics Timeline

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use